Head and Neck Cancer: ASCO 2025 Treatment Insights with Dr. Victoria Villaflor скачать в хорошем качестве

Head and Neck Cancer: ASCO 2025 Treatment Insights with Dr. Victoria Villaflor

ARTICLE: https://oncologytube.com/head-neck-ca... Join Dr. Victoria M. Villaflor, MD, Professor and Director of Head and Neck Oncology at UCI Health, as she shares critical ASCO 2025 head and neck cancer insights from the MOASC Spotlight 2025 in Newport, California. Filmed on September 16, 2025, this interview explores game-changing treatments for cutaneous SCC, HNSCC, and nasopharyngeal cancer (NPC). Learn about cemiplimab, nivolumab, and Becotatug vedotin from key trials like C-POST, NIVOPOSTOP, and Keynote 689. Timestamps: 0:00 - Introduction: Dr. Victoria Villaflor on Head and Neck Cancer 0:45 - Cemiplimab: Practice-Changing Trial for Cutaneous SCC 2:30 - Nivolumab vs. Pembrolizumab: Tailoring HNSCC Treatment 5:15 - Becotatug Vedotin: New Hope for Advanced NPC 8:00 - Multidisciplinary Team Approach and Challenges 10:00 - Closing Thoughts and Future Directions Key Quotes: "Cemiplimab was a practice-changing trial. For cutaneous squamous cell carcinoma with high-risk features, I’d be inclined to give adjuvant cemiplimab after surgery and radiation." "Somebody with a rapidly growing tumor or high risk of airway loss might be better for the nivolumab post-op regimen: surgery, then nivolumab with chemo and radiation." "The new EGFR-directed ADC, Becotatug vedotin, gives us more tools to help patients with advanced nasopharyngeal cancer live longer after initial treatments fail." Video interviews to be posted from this event at these websites... https://oncologytube.com/tag/moasc/ https://moasc.org/ About OncologyTube.com: OncologyTube.com is a free video-sharing platform dedicated to oncology professionals, offering cancer research updates through videos, audio, PowerPoint presentations, and more. Visit OncologyTube.com for a detailed web post on this and many other cancer topics and oncology insights. Follow OncologyTube: eNewsletter: https://oncologytube.com/newsletter/ Twitter:   / oncologytube   LinkedIn:   / oncologytube-com   Facebook:   / oncologytube   Instagram:   / oncologytube   YouTube:    / oncologytube   Connect with Us: Share your thoughts in the comments! Join the discussion.